218 related articles for article (PubMed ID: 4557145)
1. A comparison of pimozide with perphenazine in the treatment of acute schizophrenic psychoses.
Svestka J; Náhunek K
Act Nerv Super (Praha); 1972; 14(2):93-4. PubMed ID: 4557145
[No Abstract] [Full Text] [Related]
2. [Comparison of triperidol with perphenazine in schizophrenic psychoses. Effect on the photomyoclonic threshold].
Náhunek K; Hádlík J; Rodová A; Misurec J; Vanýsek J
Act Nerv Super (Praha); 1970 Jan; 12(1):56-7. PubMed ID: 4907390
[No Abstract] [Full Text] [Related]
3. [Controlled comparative study of methylperidol and perphenazine in schizoprenic psychoses].
Svestka J; Náhunek K
Act Nerv Super (Praha); 1970 Jan; 12(1):57-8. PubMed ID: 4907391
[No Abstract] [Full Text] [Related]
4. A pilot study of pimozide in chronic schizophrenic patients.
Sugerman AA
Curr Ther Res Clin Exp; 1971 Nov; 13(11):706-13. PubMed ID: 5000718
[No Abstract] [Full Text] [Related]
5. A controlled comparison of oxypertine and perphenazine in schizophrenic psychoses.
Svestka J; Náhunek K; Rodová A; Cesková E
Act Nerv Super (Praha); 1974 Aug; 16(3):165-6. PubMed ID: 4608706
[No Abstract] [Full Text] [Related]
6. [Clinical evaluation of a butyrophenone derivative, methylperidol, in 40 cases of schizophrenia and other psychoses].
Vinci M
Osp Psichiatr; 1971; 39(2):399-407. PubMed ID: 4948707
[No Abstract] [Full Text] [Related]
7. Evaluation of clinical efficacy of pimozide as maintenance therapy in chronic schizophrenic patients.
Singh AN
Curr Ther Res Clin Exp; 1971 Nov; 13(11):695-705. PubMed ID: 5000717
[No Abstract] [Full Text] [Related]
8. [Therapy of schizophrenic syndromes with a delayed-action drug: pimozide].
Goldwurm G; Cocchi A; Perosino N
Clin Ter; 1971 Jul; 57(6):527-39. PubMed ID: 5167550
[No Abstract] [Full Text] [Related]
9. [Controlled studies with thiothixene and perphenazine in schizophrenic psychoses].
Hádlík J; Svestka J; Náhunek K; Rodová A
Act Nerv Super (Praha); 1970 Jan; 12(1):60-1. PubMed ID: 4907392
[No Abstract] [Full Text] [Related]
10. Pimozide treatment of chronic schizophrenics as compared with haloperidol and penfluridol maintenance treatment. A multidisciplinary approach.
Baro F; Van Lommel R; Dom R; De Mesmaecker L
Acta Psychiatr Belg; 1972 Mar; 72(2):199-214. PubMed ID: 5056015
[No Abstract] [Full Text] [Related]
11. Evaluation of piperacetazine (Quide) injection in acute schizophrenics.
Kiev A; Güclü B; Kulkarni AS
Curr Ther Res Clin Exp; 1972 Jul; 14(7):376-80. PubMed ID: 4625517
[No Abstract] [Full Text] [Related]
12. [Comparison of the therapeutic effect of triperidol with perphenazine in schizophrenia].
Náhunek K; Hádlik J; Svestka J; Rodová A; Vanýsek J
Cesk Psychiatr; 1969 Oct; 65(5):281-9. PubMed ID: 5363280
[No Abstract] [Full Text] [Related]
13. An international double-blind clinical evaluation of pimozide.
Janssen P; Brugmans J; Dony J; Schuermans V
J Clin Pharmacol New Drugs; 1972 Jan; 12(1):26-34. PubMed ID: 4550223
[No Abstract] [Full Text] [Related]
14. Pimozide: a comparative study in the treatment of chronic schizophrenic patients.
Pinard G; Prénoveau Y; Fliesen W; Elie R; Bielmann P; Lamontagne Y; Tétreault L
Int J Clin Pharmacol; 1972 Apr; 6(1):22-7. PubMed ID: 4558783
[No Abstract] [Full Text] [Related]
15. Pimozide as maintenance treatment in chronic schizophrenia.
Br J Clin Pract; 1971 Sep; 25(9):417-20. PubMed ID: 4939599
[No Abstract] [Full Text] [Related]
16. [Clinical trial with R-3345].
Bastos O; Carvalho RG
J Bras Psiquiatr; 1970; 19(3):251-6. PubMed ID: 4949175
[No Abstract] [Full Text] [Related]
17. [Open and double-blind study of a new neuroleptic with prolonged action: pimozide (R 6238)].
Goldwurm G; Cocchi A; Perosino N; Rossella E; Terranova R
Clin Ter; 1971 Jun; 57(5):431-9. PubMed ID: 5113574
[No Abstract] [Full Text] [Related]
18. [Clinical comparison of methophenazine and perphenazine in schizophrenia. A controlled study. Effects on the photomyoclonic threshold].
Náhunek K; Svestka J; Misurec J
Act Nerv Super (Praha); 1967 Nov; 9(4):404-5. PubMed ID: 4889075
[No Abstract] [Full Text] [Related]
19. Penfluridol (R 16341). A long-acting oral neuroleptic, as maintenance therapy for schizophrenic and mentally retarded patients. A placebo-controlled double-blind trial.
Zwanikken GJ
Psychiatr Neurol Neurochir; 1973; 76(2):83-92. PubMed ID: 4573494
[No Abstract] [Full Text] [Related]
20. An early clinical trial of lenperone (AHR 2277), a butyrophenone, in chronic schizophrenia.
Simpson GM; Varga V
Curr Ther Res Clin Exp; 1974 May; 16(5):477-82. PubMed ID: 4209063
[No Abstract] [Full Text] [Related]
[Next] [New Search]
